Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
J.P. Morgan Healthcare Conference
Biotech
Lilly inks $2.5B Scorpion buyout in twist to breast cancer tale
Lilly is reenergizing its attempt to challenge Novartis and Roche with a deal to buy Scorpion’s PI3Kα pipeline for up to $2.5 billion.
Nick Paul Taylor
Jan 13, 2025 9:55am
JPM24 opens with ADCs the hottest ticket in San Francisco
Jan 8, 2024 6:30am
AI can make plenty of molecules, Generate can't do it alone
Jan 4, 2024 6:00am
Big data, labor shortages and slow M&A top medtech CEOs' minds
Jan 18, 2023 9:50am
JPM23: What's medtech's place at the conference? CEOs weigh in
Jan 12, 2023 9:45am
JPM23: What testmakers like Freenome are taking away from COVID
Jan 10, 2023 10:10am
